Related Experiment Video
Updated: Jan 30, 2026

Terahertz Microfluidic Sensing Using a Parallel-plate Waveguide Sensor
Published on: August 30, 2012
Synergistic terahertz platforms for precision oncology.
Yan Chen1,2, Xiaodan Kou1, Jing Zou3
1Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610000, China.
Terahertz (THz) technology offers promising advancements for precision oncology, overcoming limitations through integration with AI and nanotechnology. These innovations enhance cancer diagnosis, treatment monitoring, and drug delivery for improved patient outcomes.
Area of Science:
- Terahertz (THz) technology applied to precision oncology.
- Interdisciplinary integration of THz technology with materials science, nanotechnology, AI, computational modeling, gene editing, and microfluidics.
Background:
- THz technology's unique physical properties (non-ionizing, water-sensitive, fingerprint recognition) offer potential for oncology.
- Current clinical applications are hindered by shallow penetration, interpretation challenges, and sensitivity limitations.
Purpose of the Study:
- To review interdisciplinary advances integrating THz technology for intelligent cancer diagnostic and therapeutic systems.
- To explore how these integrated approaches address existing technical barriers and enable multifunctional theranostic systems.
Main Methods:
- Integration of THz technology with metamaterials/nanostructures for enhanced biomarker detection sensitivity.
- Application of Artificial Intelligence (AI) algorithms for rapid, accurate interpretation of THz spectral data.
- Convergence with microfluidics and CRISPR-based systems for ultra-sensitive liquid biopsy platforms.
Main Results:
- Enhanced sensitivity for trace-level biomarker detection through THz combined with nanostructures.
- Automated, accurate cancer diagnosis enabled by AI interpretation of complex THz spectral data.
- Development of ultra-sensitive liquid biopsy platforms via microfluidics and gene editing systems.
Conclusions:
- Integrated THz approaches overcome limitations, paving the way for practical, multifunctional theranostic systems in oncology.
- Cross-disciplinary collaboration is crucial for optimizing THz technology for accurate, effective, and personalized cancer care.
- Future potential lies in translating THz technology from foundational research to significant clinical impact in oncology.
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
The Precise Definition of a Limit
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Uncertainty in Measurement: Significant Figures

